| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2021-01-05 22:55:51 UTC |
|---|
| Updated at | 2021-07-15 17:14:59 UTC |
|---|
| NP-MRD ID | NP0013622 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Xyloketal B |
|---|
| Provided By | NPAtlas |
|---|
| Description | Xyloketal B is found in Xylaria. Xyloketal B was first documented in 2014 (PMID: 25546517). Based on a literature review very few articles have been published on (4R,7R,15R,18R)-4,7,15,18-tetramethyl-3,5,14,16-tetraoxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁵,¹⁹]Icosa-1(13),2(10),11-trien-11-ol (PMID: 34375691) (PMID: 34338497) (PMID: 30643385) (PMID: 30572607). |
|---|
| Structure | [H]OC1=C2C(O[C@]3(OC([H])([H])[C@]([H])(C([H])([H])[H])[C@]3([H])C2([H])[H])C([H])([H])[H])=C2C(O[C@]3(OC([H])([H])[C@]([H])(C([H])([H])[H])[C@]3([H])C2([H])[H])C([H])([H])[H])=C1[H] InChI=1S/C20H26O5/c1-10-9-23-20(4)14(10)5-12-16(21)7-17-13(18(12)25-20)6-15-11(2)8-22-19(15,3)24-17/h7,10-11,14-15,21H,5-6,8-9H2,1-4H3/t10-,11-,14-,15-,19+,20+/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C20H26O5 |
|---|
| Average Mass | 346.4230 Da |
|---|
| Monoisotopic Mass | 346.17802 Da |
|---|
| IUPAC Name | (4R,7R,8S,15R,18R,19S)-4,7,15,18-tetramethyl-3,5,14,16-tetraoxapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{15,19}]icosa-1,10,12-trien-11-ol |
|---|
| Traditional Name | (4R,7R,8S,15R,18R,19S)-4,7,15,18-tetramethyl-3,5,14,16-tetraoxapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{15,19}]icosa-1,10,12-trien-11-ol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | C[C@H]1CO[C@]2(C)OC3=C4CC5[C@@H](C)CO[C@]5(C)OC4=CC(O)=C3CC12 |
|---|
| InChI Identifier | InChI=1S/C20H26O5/c1-10-9-23-20(4)14(10)5-12-16(21)7-17-13(18(12)25-20)6-15-11(2)8-22-19(15,3)24-17/h7,10-11,14-15,21H,5-6,8-9H2,1-4H3/t10-,11-,14?,15?,19+,20+/m0/s1 |
|---|
| InChI Key | CCNANHBVUNZCKA-RMMANXQQSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | | Species Name | Source | Reference |
|---|
| Xylaria | NPAtlas | |
|
|---|
| Chemical Taxonomy |
|---|
| Classification | Not classified |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Xiao AJ, Chen W, Xu B, Liu R, Turlova E, Barszczyk A, Sun CL, Liu L, Deurloo M, Wang GL, Feng ZP, Sun HS: Marine compound xyloketal B reduces neonatal hypoxic-ischemic brain injury. Mar Drugs. 2014 Dec 24;13(1):29-47. doi: 10.3390/md13010029. [PubMed:25546517 ]
- Gong H, Bandura J, Wang GL, Feng ZP, Sun HS: Xyloketal B: A marine compound with medicinal potential. Pharmacol Ther. 2021 Aug 7:107963. doi: 10.1016/j.pharmthera.2021.107963. [PubMed:34375691 ]
- Tong Y, Mukhamejanova Z, Zheng Y, Wen T, Xu F, Pang J: Marine-Derived Xyloketal Compound Ameliorates MPP(+)-Induced Neuronal Injury through Regulating of the IRE1/XBP1 Signaling Pathway. ACS Chem Neurosci. 2021 Aug 2. doi: 10.1021/acschemneuro.1c00362. [PubMed:34338497 ]
- Liang F, Su F, Wang X, Long S, Zheng Y, He X, Pang J, Pei Z: Xyloketal derivative C53N protects against mild traumatic brain injury in mice. Drug Des Devel Ther. 2018 Dec 27;13:173-182. doi: 10.2147/DDDT.S177951. eCollection 2019. [PubMed:30643385 ]
- Gong H, Luo Z, Chen W, Feng ZP, Wang GL, Sun HS: Marine Compound Xyloketal B as a Potential Drug Development Target for Neuroprotection. Mar Drugs. 2018 Dec 19;16(12). pii: md16120516. doi: 10.3390/md16120516. [PubMed:30572607 ]
|
|---|